SalvaRx Group (SALV) Sets New 12-Month Low at $10.20

SalvaRx Group Plc (LON:SALV) shares reached a new 52-week low on Wednesday . The stock traded as low as GBX 10.20 ($0.13) and last traded at GBX 20 ($0.26), with a volume of 57068 shares traded. The stock had previously closed at GBX 73.50 ($0.96).

Separately, Northland Securities restated a “corporate” rating on shares of SalvaRx Group in a research note on Tuesday, December 11th.

ILLEGAL ACTIVITY NOTICE: This piece was published by PressOracle and is the sole property of of PressOracle. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at

About SalvaRx Group (LON:SALV)

SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.

Featured Article: How are the companies in the S&P 500 selected?

Receive News & Ratings for SalvaRx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SalvaRx Group and related companies with's FREE daily email newsletter.

Leave a Reply

Leave a Reply